Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Ryan

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Cancer|September 13, 2007
The hazards of intermediate endpointsTomasz M Beer, Christopher W Ryan
Current Treatment Options in Oncology|May 16, 2015
Preoperative therapy for extremity soft tissue sarcomasLara E Davis, Christopher W Ryan
Urologic Oncology|July 16, 2005
Current clinical trials in renal cell carcinomaMitchell H Sokoloff, Siamak Daneshmand, Christopher W Ryan
BJU International|April 21, 2005
A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancerChristopher W Ryan, Walter M Stadler, Nicholas J Vogelzang
The Journal of Urology|December 14, 2007
Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapyRon S Israeli, Christopher W Ryan, Laura L Jung
Lancet (London, England)|November 9, 2024
Adjuvant everolimus after renal cell carcinoma nephrectomy - Authors' replyChristopher W Ryan, Catherine M Tangen, Primo N Lara
Cancer|August 14, 2002
A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinomaChristopher W Ryan, Nicholas J Vogelzang, Walter M Stadler
Archives of Pathology & Laboratory Medicine|March 26, 2003
Angiosarcoma masquerading as embryonal carcinoma in the metastasis from a mature testicular teratomaSunati Sahoo, Christopher W Ryan, Wendy M Recant, et al.
BJU International|September 13, 2005
A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapyNancy B Davis, Christopher W Ryan, Walter M Stadler, et al.
Environmental Management|October 21, 2022
Evaluating Mechanisms of Short-term Woodland Salamander Response to Forest ManagementEric L Margenau, Petra B Wood, Donald J Brown, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Cancer|September 13, 2007
The hazards of intermediate endpointsTomasz M Beer, Christopher W Ryan
Current Treatment Options in Oncology|May 16, 2015
Preoperative therapy for extremity soft tissue sarcomasLara E Davis, Christopher W Ryan
Urologic Oncology|July 16, 2005
Current clinical trials in renal cell carcinomaMitchell H Sokoloff, Siamak Daneshmand, Christopher W Ryan
BJU International|April 21, 2005
A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancerChristopher W Ryan, Walter M Stadler, Nicholas J Vogelzang
The Journal of Urology|December 14, 2007
Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapyRon S Israeli, Christopher W Ryan, Laura L Jung
Lancet (London, England)|November 9, 2024
Adjuvant everolimus after renal cell carcinoma nephrectomy - Authors' replyChristopher W Ryan, Catherine M Tangen, Primo N Lara
Cancer|August 14, 2002
A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinomaChristopher W Ryan, Nicholas J Vogelzang, Walter M Stadler
Archives of Pathology & Laboratory Medicine|March 26, 2003
Angiosarcoma masquerading as embryonal carcinoma in the metastasis from a mature testicular teratomaSunati Sahoo, Christopher W Ryan, Wendy M Recant, et al.
BJU International|September 13, 2005
A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapyNancy B Davis, Christopher W Ryan, Walter M Stadler, et al.
Environmental Management|October 21, 2022
Evaluating Mechanisms of Short-term Woodland Salamander Response to Forest ManagementEric L Margenau, Petra B Wood, Donald J Brown, et al.
Pageof 12